These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38933532)

  • 21. Editing the immunopeptidome of melanoma cells using a potent inhibitor of endoplasmic reticulum aminopeptidase 1 (ERAP1).
    Koumantou D; Barnea E; Martin-Esteban A; Maben Z; Papakyriakou A; Mpakali A; Kokkala P; Pratsinis H; Georgiadis D; Stern LJ; Admon A; Stratikos E
    Cancer Immunol Immunother; 2019 Aug; 68(8):1245-1261. PubMed ID: 31222486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MHC-associated peptide proteomics enabling highly sensitive detection of immunogenic sequences for the development of therapeutic antibodies with low immunogenicity.
    Sekiguchi N; Kubo C; Takahashi A; Muraoka K; Takeiri A; Ito S; Yano M; Mimoto F; Maeda A; Iwayanagi Y; Wakabayashi T; Takata S; Murao N; Chiba S; Ishigai M
    MAbs; 2018; 10(8):1168-1181. PubMed ID: 30199322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MHC class I antigen presentation and implications for developing a new generation of therapeutic vaccines.
    Comber JD; Philip R
    Ther Adv Vaccines; 2014 May; 2(3):77-89. PubMed ID: 24790732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer-specific T helper shared and neo-epitopes uncovered by expression of the MHC class II master regulator CIITA.
    Hos BJ; Tondini E; Camps MGM; Rademaker W; van den Bulk J; Ruano D; Janssen GMC; de Ru AH; van den Elsen PJ; de Miranda NFCC; van Veelen PA; Ossendorp F
    Cell Rep; 2022 Oct; 41(2):111485. PubMed ID: 36223747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificity.
    Denkberg G; Cohen CJ; Lev A; Chames P; Hoogenboom HR; Reiter Y
    Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9421-6. PubMed ID: 12093904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accurate prediction of major histocompatibility complex class II epitopes by sparse representation via ℓ 1-minimization.
    Aguilar-Bonavides C; Sanchez-Arias R; Lanzas C
    BioData Min; 2014; 7():23. PubMed ID: 25392716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defining promiscuous MHC class II helper T-cell epitopes for the HER2/neu tumor antigen.
    Kobayashi H; Wood M; Song Y; Appella E; Celis E
    Cancer Res; 2000 Sep; 60(18):5228-36. PubMed ID: 11016652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Harnessing Fuzzy Rule Based System for Screening Major Histocompatibility Complex Class I Peptide Epitopes from the Whole Proteome: An Implementation on the Proteome of
    Vijayakumar S
    J Comput Biol; 2022 Sep; 29(9):1045-1058. PubMed ID: 35404099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficient MHC class I-peptide binding is required but does not ensure MHC class I-restricted immunogenicity.
    Feltkamp MC; Vierboom MP; Kast WM; Melief CJ
    Mol Immunol; 1994 Dec; 31(18):1391-401. PubMed ID: 7823965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance Evaluation of MHC Class-I Binding Prediction Tools Based on an Experimentally Validated MHC-Peptide Binding Data Set.
    Bonsack M; Hoppe S; Winter J; Tichy D; Zeller C; Küpper MD; Schitter EC; Blatnik R; Riemer AB
    Cancer Immunol Res; 2019 May; 7(5):719-736. PubMed ID: 30902818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigen processing and presentation in cancer immunotherapy.
    Lee MY; Jeon JW; Sievers C; Allen CT
    J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32859742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virus-like particle-mediated delivery of structure-selected neoantigens demonstrates immunogenicity and antitumoral activity in mice.
    Barajas A; Amengual-Rigo P; Pons-Grífols A; Ortiz R; Gracia Carmona O; Urrea V; de la Iglesia N; Blanco-Heredia J; Anjos-Souza C; Varela I; Trinité B; Tarrés-Freixas F; Rovirosa C; Lepore R; Vázquez M; de Mattos-Arruda L; Valencia A; Clotet B; Aguilar-Gurrieri C; Guallar V; Carrillo J; Blanco J
    J Transl Med; 2024 Jan; 22(1):14. PubMed ID: 38172991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-based prediction of MHC-peptide association: algorithm comparison and application to cancer vaccine design.
    Schiewe AJ; Haworth IS
    J Mol Graph Model; 2007 Oct; 26(3):667-75. PubMed ID: 17493854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MHCSeqNet2-improved peptide-class I MHC binding prediction for alleles with low data.
    Wongklaew P; Sriswasdi S; Chuangsuwanich E
    Bioinformatics; 2024 Jan; 40(1):. PubMed ID: 38152987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites.
    Rajnavölgyi E; Horváth A; Gogolák P; Tóth GK; Fazekas G; Fridkin M; Pecht I
    Eur J Immunol; 1997 Dec; 27(12):3105-14. PubMed ID: 9464794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative Prediction of the Landscape of T Cell Epitope Immunogenicity in Sequence Space.
    Ogishi M; Yotsuyanagi H
    Front Immunol; 2019; 10():827. PubMed ID: 31057550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of the cognate peptide-MHC target of T cell receptors using molecular modeling and force field scoring.
    Lanzarotti E; Marcatili P; Nielsen M
    Mol Immunol; 2018 Feb; 94():91-97. PubMed ID: 29288899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes.
    Poran A; Harjanto D; Malloy M; Arieta CM; Rothenberg DA; Lenkala D; van Buuren MM; Addona TA; Rooney MS; Srinivasan L; Gaynor RB
    Genome Med; 2020 Aug; 12(1):70. PubMed ID: 32791978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.